SPONSOR
National Cancer Institute, Naples
Total Trials
7
Recruiting
7
Phases
Phase 2
Conditions studied: Lung Neuroendocrine NeoplasmGEP Neuroendocrine TumorSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the AnusLocally Advanced Rectal Cancer (LARC)Colorectal CancerADCCAdenocarcinoma of the PancreasColorectal Cancer (CRC)Endometrial Cancer
National Cancer Institute, Naples is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Lung Neuroendocrine Neoplasm, GEP Neuroendocrine Tumor, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Cancer Institute, Naples
How many clinical trials has National Cancer Institute, Naples sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by National Cancer Institute, Naples, of which 7 are actively recruiting participants. These trials cover conditions including Lung Neuroendocrine Neoplasm, GEP Neuroendocrine Tumor, Squamous Cell Carcinoma of the Head and Neck. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Cancer Institute, Naples research focus on?
National Cancer Institute, Naples clinical trials span Lung Neuroendocrine Neoplasm, GEP Neuroendocrine Tumor, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus, Locally Advanced Rectal Cancer (LARC), and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Cancer Institute, Naples clinical trial?
To participate in a National Cancer Institute, Naples trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Cancer Institute, Naples trials with current recruitment status updated daily.
Clinical Trials by National Cancer Institute, Naples
NCT04893785 Phase 2
Recruiting
A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
Lung Neuroendocrine Neoplasm
NCT06236464
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Squamous Cell Carcinoma of the Head and Neck
NCT07269249
Recruiting
Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer (LARC)
NCT03874026 Phase 2
Recruiting
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
Colorectal Cancer
NCT05821556 Phase 2
Recruiting
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Adenocarcinoma of the Pancreas
NCT06886282
Recruiting
Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease
Colorectal Cancer (CRC)
NCT07027046
Recruiting
Application of da Vinci SP for Endometrial Cancer Surgical Staging
Endometrial Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology